PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil

dc.contributor.authorSenna, k
dc.contributor.authorSilva, G
dc.contributor.authorTura, BR
dc.date.accessioned2022-10-07T13:50:33Z
dc.date.available2022-10-07T13:50:33Z
dc.date.issued2018
dc.description.abstractKnee osteoarthritis is the most common form of joint disease and has been shown to be associated with aging. It affects 3.8% of the population, worldwide, and causes significant disability, impairing patient’s quality of life. Current treatment options are as follows: pharmacological, non-pharmacological and surgical. Viscosupplementation is a treatment with exogenous hyaluronic acid applied to the knees for symptom relief and postponing surgery. This study aims to estimate the budget impact of viscosupplementation treatment for knee osteoarthritis.
dc.identifier.citationSenna KMS, Silva G, Tura BR. PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil. Value in Health.2018;21(suppl 3):S290.
dc.identifier.doiDOI: 10.1016/j.jval.2018.09.1732
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/323
dc.language.isoen
dc.publisherValue in Health
dc.subjectBudget impact analysisen
dc.subjectKnee osteoarthritisen
dc.subjectTreatmenten
dc.titlePMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazilen
dc.typePresentation
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Produção Técnica_Senna k, Silva G, Tura BR_2018.pdf
Tamanho:
378.47 KB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: